Since Cage had already worked with the indole hallucinogens, Belotti gave him pretty much of a free hand. After a couple of frustrating months, he began to look seriously at DMD. It seemed to fit the specifications, except that animal tests did not show significant psychoactive effect. He worried that it might be too subtle. No matter how safe it was, the stuff was no good if it left the user straight as a Baptist accountant. Still Cage was able to convince Belotti to authorize microiontophoretic tests on rats.